Insider filing
Traded Jan 2 · filed 4 days later
Routine share withholding; mechanical by default.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 5, 2025 · Filed Dec 8, 2025
An Insulet director paid $300K out of pocket for Insulet shares. Shares held went up 27% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$299,884
Shares × reported transaction price
$100K–$500K
+26.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
29 days after results of Nov 6, 2025, 75 days before results of Feb 18, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $304.49 on Dec 5, 2025, 28% above its 52-week low and 14% below its high, after a 6% drop over the previous 30 trading days
52-week range $237.06 (Mar 10, 2025) to $352.82 (Sep 9, 2025), 58% of the way up, from 250 adjusted closes. 30 trading days earlier: $323.46 on Oct 23, 2025. Describes the past only, not a forecast
RSI 41, 1% above its 200-day average, 5% under its 50-day average, 14% below the 52-week high, 20-day volatility 55% a year, against the S&P 500: −4 points over 1 month, −19 points over 3 months, −17 points over 6 months
From the adjusted closes up to Dec 5, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 6 days before PODD filed an 8-K: changed a top executive or board member (Dec 11, 2025). The first open-market purchase by any PODD insider since Aug 2024. Timothy C. Stonesifer's first open-market purchase of PODD in filings since 2007
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.9% | −0.6% | −1.3% |
| 30 days | −0.5% | +0.9% | −1.4% |
| 90 days | −18.3% | −0.7% | −17.6% |
| 180 days | −48.5% | +8.2% | −56.7% |
Past results only. Not a forecast.
Insider filing
Traded Jan 2 · filed 4 days later
Routine share withholding; mechanical by default.
Insider filing
Traded Dec 31, 2025 · filed 6 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider selling
Traded Dec 15, 2025 · filed 1 day laterNot reported under a pre-arranged trading plan
An Insulet director sold $543K of Insulet shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.